Cold temperatures slam the brakes on these molecular interactions, preserving the peptides integrity for the long haul
Unlike many peptides that degrade quickly in the digestive system, BPC-157 demonstrates remarkable stability and bioavailability, making it effective through multiple administration routes including oral, subcutaneous, and intramuscular delivery
We focus on: Clinically studied ingredients
BPC-157 administration in intestinal resection models promoted adaptive mucosal hypertrophy increased villus height and crypt depth in the remaining bowel, suggesting it may act as an intestinal trophic factor in contexts requiring adaptation
At the gene level it modulates over 4,000 human genes, including 47 directly involved in DNA repair
Find vetted peptide therapy clinics near you